Literature DB >> 29280017

Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes.

Chonticha Suwattanasophon1,2,3, Napat Songtawee4, Peter Wolschann5,3, Kiattawee Choowongkomon6,7.   

Abstract

The family of human epidermal growth factor receptors (HER) is involved in tumor cell growth. Homodimerization and heterodimerization of the HER family are important for activation of these receptors. The structures of homodimer conformation are well characterized, while the structures of heterodimer conformations, especially between HER1 and HER2, are not completely understood. In this study, two models of possible asymmetric HER1/HER2 kinase domains were built. Molecular dynamics simulations and molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) methods were applied to examine the possibility of these two-heterodimer interactions. From our results, it could be concluded that the HER2 kinase domain prefers to serve as the receiver rather than the activator. Key binding residues of this dimer complex at N lobe of HER2 is ALA683 and at C lobe of HER1 are GLU914, GLU917, and ASP930. This study will be useful in allowing us to predict and be able to control activity of this enzyme in disease in the future. Graphical abstract A model of the asymmetric dimer of HER1-HER2 heterodimer with key intereaction residues in (a) HER1A and (b) HER2R by molecular dynamic simulation.

Entities:  

Keywords:  ErbB2; HER family; HER1; Heterodimer; Molecular dynamics simulation

Mesh:

Substances:

Year:  2017        PMID: 29280017     DOI: 10.1007/s00894-017-3544-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  22 in total

1.  ModLoop: automated modeling of loops in protein structures.

Authors:  András Fiser; Andrej Sali
Journal:  Bioinformatics       Date:  2003-12-12       Impact factor: 6.937

2.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Canonical sampling through velocity rescaling.

Authors:  Giovanni Bussi; Davide Donadio; Michele Parrinello
Journal:  J Chem Phys       Date:  2007-01-07       Impact factor: 3.488

4.  The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.

Authors:  Xiangdong Zhou; Yehenew M Agazie
Journal:  Cell Signal       Date:  2011-09-03       Impact factor: 4.315

5.  g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.

Authors:  Rashmi Kumari; Rajendra Kumar; Andrew Lynn
Journal:  J Chem Inf Model       Date:  2014-06-19       Impact factor: 4.956

Review 6.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

Review 7.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 8.  A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy.

Authors:  Jeroen Claus; Gargi Patel; Tony Ng; Peter J Parker
Journal:  Biochem Soc Trans       Date:  2014-08       Impact factor: 5.407

Review 9.  The ErbB/HER family of protein-tyrosine kinases and cancer.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2013-11-20       Impact factor: 7.658

10.  HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.

Authors:  Z Hartman; H Zhao; Y M Agazie
Journal:  Oncogene       Date:  2012-10-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.